StockData

Cohu vs inTEST

COHU and INTT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How COHU and INTT compare

Cohu is the larger company, worth 12 times as much as inTEST ($2.1B against $176M).

Cohu grew revenue faster over the last twelve months (34.0% versus 16.6% for inTEST).

inTEST keeps more of each dollar of sales as profit, with a net margin of 2.7% compared with −4.0% at Cohu.

inTEST scores higher on the StockData Score (11 against 8 for Cohu), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCOHUINTT
Size and price
Market cap$2.1B$176M
Share price$43.59$13.73
Change, 1 year89.3%64.6%
Change, 5 years18.4%−12.9%
Beta (5Y)1.681.36
Employees2,857407
StockData Score
Total score811 (better)
Valuation score11
Growth score23 (better)
Performance score02 (better)
Health score55
Dividend score00
Valuation
P/E–45.8×
P/S3.6×1.3× (better)
P/B2.6×1.6× (better)
EV/EBITDA66.1×14.6× (better)
P/FCF37.0×–
FCF yield2.7% (better)−0.14%
Fair value$19.93$11.64
Margin of safety−119%−17.9% (better)
Growth
Revenue growth (TTM)34.0% (better)16.6%
Revenue growth, 5Y average−6.6%16.2% (better)
Profitability
Gross margin44.5% (better)44.2%
Operating margin−2.4%3.3% (better)
Net margin−4.0%2.7% (better)
FCF margin9.8% (better)−0.17%
Return on equity−2.8%3.5% (better)
Return on invested capital−1.7%4.0% (better)
Financial health
Debt / equity0.380.05 (better)
Net debt / EBITDA−7.32−1.39
Interest coverage−2.0×13.3× (better)
Current ratio5.16 (better)2.63
Altman Z-score3.664.48 (better)
Piotroski F-score55
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00%0.00%
Ownership
Held by institutions116%67.3%
Held by insiders4.4%5.7%
Insider net buying, 12 months−$13.0M−$57.8K (better)
Short interest, % of float19.4%2.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.